• EN
  • Faire un don
  • À propos
    • C’est quoi l’ARSACS?
    • Notre mission
    • What We Do
    • Our Team
      • Founders
      • Board of Directors
      • Chercheurs
    • Privacy Policy
  • Personnes atteintes de l’ARSACS
    • International Patient Registry
    • Frequently Asked Questions
    • Patient Participation
      • Research Study
    • Connect with ARSACS Community
    • ARSACS Exercise Program at Home
  • Research
    • Research Projects
    • Research Project Reports
    • Research Grants
    • Research Tools
    • Partnerships
    • Preclinical and Clinical Trials
    • Publications
  • How You Can Help
  • Conferences & Events
    • 2026 International ARSACS Symposium
  • News
  • Contact

Identification of a novel SACS gene mutation leading to spastic ataxia Charlevoix-Saguenay type: a case report

Août 1, 2025 | Publications

Identification of a novel SACS gene mutation leading to spastic ataxia Charlevoix-Saguenay type: a case report – . Research conducted in Uruguay and published in the Journal of Medical Case Reports in August 2025..

Running in support of families affected by ARSACS

Running in support of families affected by ARSACS

Avr 8, 2026 | Dernières nouvelles

read more...

Dimethyl Fumarate Tested in an ARSACS Mouse Model

Mar 31, 2026 | Research Project Reports

read more...
Newsletter #6  Winter 2026 Edition

Infolettre #6 Édition Hiver 2026

Mar 12, 2026 | Dernières nouvelles, Uncategorized

read more...
« Older Entries


Location

1000 Sherbrooke O, bur. 2100, Montréal, QC H3A 3G4



Contact

1 (514) 370-3625
ataxie@arsacs.com

Contact Ataxia Charlevoix-Saguenay Foundation

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.

Copyright © 2026, Ataxia Charlevoix-Saguenay Foundation, 856980321RR0001

  • Follow
  • Follow